Targeting Cognition in Early Alzheimer's Disease by Improving Sleep With Trazodone — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Targeting Cognition in Early Alzheimer's Disease by Improving Sleep With Trazodone — Stella

Home/AMCI - Amnestic Mild Cognitive Impairment/

View on ClinicalTrials.gov

Recruiting

Back to AMCI - Amnestic Mild Cognitive Impairment trials

Phase 2 — Testing in a larger group (up to a few hundred people) to further evaluate safety and begin to assess effectiveness.

Trial locations(1 site)

United States

Johns Hopkins Hospital, Baltimore, Maryland

Key details

Phase

Safety & dosing

Sponsor

Johns Hopkins University

Collaborators

National Institute on Aging (NIA)

Enrollment target

~100 participants

Started

February 2023

Primary completion

July 2027

Age range

55 Years and older

Last updated September 2025

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.